Tag Archive for: Heart

According to real-world data, obesity meds help prevent heart problemsAdobe stock photos - Dzmitry
Obesity medicines

Semaglutide and tirzepatide significantly improve heart health

Semaglutide (Ozempic®) and Tirzepatide (Mounjaro®) not only promote weight loss but also significantly reduce the risk of major cardiovascular events in patients with type 2 diabetes. Real-world evidence from the Technical University of Munich and Harvard Medical School shows up to 18% lower risk of heart attack and stroke, highlighting the growing potential of GLP-1 therapies in cardiometabolic care.

Read more
Claudia Ulbrich, MD, CEO und Prof. Thomas Thum, MD, PhD, CSO/CMO at Cardior Pharmaceuticals. © Cardior Pharmaceuticals
acquisition

Novo Nordisk to acquire Cardior Pharmaceuticals

Novo Nordisk is set to acquire German miRNA blocker specialist Cardior Pharmaceuticals GmbH for up to €1.025bn including milestone payments.

Read more
Treatment with the agonistic TREM2 antibody 4D9 leads to the formation of smaller necrotic cores (red outlines) in atherosclerotic plaques of the aortic root in Ldlr-/- mice. © Nature Cardiovascular Research
atherosclerosis

Researcher find potential target for atherosclerosis

TREM2, a receptor on the surface of macrophages, reduces necrotic core formation in early atherosclerosis, a German-Austrian reseach team reports.

Read more
Heart moves moneyPixabay.com

Andera Partners co-leads $118m Series B of Mineralys thx (USA)

Andera Partners, Paris based European private equity player, announced on Wednesday that, together with RA Capital Management, it is leading an oversubscribed and up-sized $118m Series B financing for Mineralys Therapeutics, Inc., Philadelphia (USA), a private, clinical-stage biopharmaceutical company  developing novel therapy for the treatment of hypertension.

Read more